Literature DB >> 12404571

The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.

P. J. Nathan1, J. Clarke, J. Lloyd, C. W. Hutchison, L. Downey, C. Stough.   

Abstract

The Ayurvedic medicine Bacopa monniera (Brahmi) has been shown to exert cognitive enhancing effects in animals. The current study examined the acute effects of an extract of Bacopa monniera on cognitive function in normal healthy human subjects. The study was a double-blind, placebo-controlled independent group design in which subjects were randomly allocated to one of two treatment conditions, Bacopa monniera (300 mg) (n = 18) or placebo (n = 20). Neuropsychological testing was conducted before and 2 h after drug administration. No significant changes were found on any of the tests. The findings suggest that Bacopa monniera, at least for the dose administered, has no acute effects on cognitive functioning in normal healthy subjects. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Year:  2001        PMID: 12404571     DOI: 10.1002/hup.306

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  24 in total

1.  Protective effect of Bacopa monniera on methyl mercury-induced oxidative stress in cerebellum of rats.

Authors:  Thangarajan Sumathi; Chandrasekar Shobana; Johnson Christinal; Chandran Anusha
Journal:  Cell Mol Neurobiol       Date:  2012-02-26       Impact factor: 5.046

Review 2.  Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.

Authors:  Chris Neale; David Camfield; Jonathon Reay; Con Stough; Andrew Scholey
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

3.  Antidepressant activity of brahmi in albino mice.

Authors:  Sldv Ramana Murty Kadali; Das M C; Srinivasa Rao A S R; Karuna Sri G
Journal:  J Clin Diagn Res       Date:  2014-03-15

4.  HPLC analysis and standardization of Brahmi vati - An Ayurvedic poly-herbal formulation.

Authors:  Amrita Mishra; Arun K Mishra; Om Prakash Tiwari; Shivesh Jha
Journal:  J Young Pharm       Date:  2013-09-30

5.  The vacuolar proton pyrophosphatase gene (SbVPPase) from the Sorghum bicolor confers salt tolerance in transgenic Brahmi [Bacopa monnieri (L.) Pennell].

Authors:  M L Ahire; S Anil Kumar; D L Punita; P S Mundada; P B Kavi Kishor; T D Nikam
Journal:  Physiol Mol Biol Plants       Date:  2018-08-09

6.  Bacopa monnieri (L.) Pennell, a potential plant species for degradation of textile azo dyes.

Authors:  Laxmi Shanmugam; Mahendra Ahire; Tukaram Nikam
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-08       Impact factor: 4.223

7.  Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.

Authors:  Vidya Sathyanarayanan; Tinku Thomas; Suzanne J L Einöther; Rajendra Dobriyal; M K Joshi; Srinivasan Krishnamachari
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

Review 8.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

9.  Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.

Authors:  Carlo Calabrese; William L Gregory; Michael Leo; Dale Kraemer; Kerry Bone; Barry Oken
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

10.  Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice.

Authors:  Sudesh Prabhakar; Manish Kumar Saraf; Promila Pandhi; Akshay Anand
Journal:  Psychopharmacology (Berl)       Date:  2008-01-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.